Who has invested in Imago BioSciences?

Merck are named among the investors backing Imago BioSciences.

Imago BioSciences Funding: $1.4B Raised, Series C (2020)

Imago BioSciences funding overview

Imago BioSciences has raised $1.4B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series C announced in November 2020. The round record for Imago BioSciences runs through 2020; nothing later has been disclosed. Investors on record include Merck.

Imago BioSciences at a glance

Total raised: $1.4B
Latest round: Series C
Latest round date: November 2020
Notable investors: Merck

Frequently asked about Imago BioSciences funding

How much has Imago BioSciences raised?: Imago BioSciences has raised $1.4B in total disclosed funding across the rounds on record.
Who has invested in Imago BioSciences?: Merck are named among the investors backing Imago BioSciences.
What was the latest Imago BioSciences funding round?: The most recent disclosed round is a Series C, announced in November 2020.
Where is Imago BioSciences based?: No headquarters location is disclosed for Imago BioSciences.
When did Imago BioSciences last raise?: The last disclosed Imago BioSciences round closed in November 2020 at Series C.

We update the Imago BioSciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Imago BioSciences Funding: $1.4B Raised, Series C (2020)

Imago BioSciences funding overview

Imago BioSciences at a glance

Frequently asked about Imago BioSciences funding

Companies related to Imago BioSciences (38)

Browse related funding lists (4)